15-Deoxy-Δ12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 3, 2010, Pages

  Watanabe, Katsutaka ^a   Yokoyama, Yukihiro ^a   Kokuryo, Toshio ^a   Kawai, Kiyotaka ^a   Kitagawa, Tomomi ^a   Seki, Takashi ^a   Nakagawa, Akifumi ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bile duct ligation; Hyaluronic acid clearance; NF B; Portal venous pressure

Indexed keywords

15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; DELTA12 PROSTAGLANDIN J2; HYALURONIC ACID; LIPOPOLYSACCHARIDE; PROSTAGLANDIN DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ACUTE OBSTRUCTIVE CHOLANGITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE DUCT LIGATION; BLOOD SAMPLING; CELL DAMAGE; CHOLANGITIS; CONTROLLED STUDY; ENDOTHELIUM CELL; INFLAMMATION; LAPAROTOMY; LIVER HISTOLOGY; LIVER INJURY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PORTAL VEIN BLOOD PRESSURE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE DUCTS; BILIRUBIN; CHOLANGITIS; CHOLESTASIS, EXTRAHEPATIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HYALURONIC ACID; INTERLEUKIN-6; LIGATION; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRCULATION; LIVER FAILURE, ACUTE; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PPAR GAMMA; PROSTAGLANDIN D2; RATS; RATS, WISTAR; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77249172193     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00233.2009     Document Type: Article

References (49)

1. Abdelrahman M, Collin M, Thiemermann C. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock 22: 555-561, 2004.
2. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127: 25-50, 1992.
3. Andrew DJ, Johnson SE. Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition. Am J Gastroenterol 54: 141-154, 1970.
4. Arai M, Mochida S, Ohno A, Fujiwara K. Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation 62: 1398-1401, 1996.
5. Ba ZF, Wang P, Koo DJ, Cioffi WG, Bland KI, Chaudry IH. Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit Care Med 28: 2837-2842, 2000.
6. Bauer M, Bauer I, Sonin NV, Kresge N, Baveja R, Yokoyama Y, Harding D, Zhang JX, Clemens MG. Functional significance of endothelin B receptors in mediating sinusoidal and extrasinusoidal effects of endothelins in the intact rat liver. Hepatology 31: 937-947, 2000.
7. Chatterjee PK, Patel NS, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Eberhardt W, Pfeilschifter J, Thiemermann C. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 61: 630-643, 2004.
8. Chuang JH, Chang NK, Huang CC, Lo SK, Wang HC, Chen CM, Wu CL, Chou MH, Lin TK. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats. J Surg Res 120: 210-218, 2004.
9. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21: 249-252, 2000.
10. Copple BL, Banes A, Ganey PE, Roth RA. Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol Sci 65: 309-318, 2002.
11. Ferguson HE, Thatcher TH, Olsen KC, Garcia-Bates TM, Baglole CJ, Kottmann RM, Strong ER, Phipps RP, Sime PJ. Peroxisome proliferator- activated receptor-γ ligands induce heme oxygenase-1 in lung fibroblasts by a PPARγ -independent, glutathione-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 297: L912-L919, 2009.
12. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12: 183-187, 1997.
13. Gee MH, Albertine KH. Neutrophil-endothelial cell interactions in the lung. Annu Rev Physiol 55: 227-248, 1993.
14. Gong JP, Liu CA, Wu CX, Li SW, Shi YJ, Li XH. Nuclear factor κB activity in patients with acute severe cholangitis. World J Gastroenterol 8: 346-349, 2002.
15. Gong JP, Wu CX, Liu CA, Li SW, Shi YJ, Li XH, Peng Y. Liver sinusoidal endothelial cell injury by neutrophils in rats with acute obstructive cholangitis. World J Gastroenterol 8: 342-345, 2002.
16. Hauser B, Kick J, Ivanyi Z, Asfar P, Ehrmann U, Muth CM, Albicini M, Wachter U, Vogt J, Bauer M, Bruckner UB, Radermacher P, Bracht H. Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. Intensive Care Med 32: 759-765, 2006.
17. Hirata K, Ogata I, Ohta Y, Fujiwara K. Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats. J Pathol 158: 157-165, 1989.
18. Jain MK, Jain R. Acute bacterial cholangitis. Curr Treat Options Gastroenterol 9: 113-121, 2006.
19. Jansen MJ, Hendriks T, Vogels MT, van der Meer JW, Goris RJ. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit Care Med 24: 1196-1202, 1996.
20. Kaplan JM, Cook JA, Hake PW, O'Connor M, Burroughs TJ, Zingarelli B. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 24: 59-65, 2005.
21. Kyokane T, Nagino M, Oda K, Nimura Y. An experimental study of selective intrahepatic biliary ablation with ethanol. J Surg Res 96: 188-196, 2001.
22. Lee CW, Chuang JH, Wang PW, Chang NK, Wang HC, Huang CC, Tiao MM, Lo SK. Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis. World J Surg 30: 2217-2226, 2006.
23. Lee YJ, Suh HN, Han HJ. Effect of BSA-induced ER stress on SGLT protein expression levels and α-MG uptake in renal proximal tubule cells. Am J Physiol Renal Physiol 296: F1405-F1416, 2009.
24. Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am 70: 1297-1312, 1990.
25. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 108: 463-469, 1995.
26. Marzocco S, Di Paola R, Mazzon E, Genovese T, Britti D, Pinto A, Autore G, Cuzzocrea S. The cyclopentenone prostaglandin 15-deoxydelta(12,14) -prostaglandin J2 attenuates the development of zymosan-induced shock. Intensive Care Med 31: 693-700, 2005.
27. Miyasaka N, Hirata Y. Nitric oxide and inflammatory arthritides. Life Sci 61: 2073-2081, 1997.
28. Moore CC, Martin EN, Lee GH, Obrig T, Linden J, Scheld WM. An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect Dis 8: 141-150, 2008.
29. Nanji AA, Tahan SR, Khwaja S, Yacoub LK, Sadrzadeh SM. Elevated plasma levels of hyaluronic acid indicate endothelial cell dysfunction in the initial stages of alcoholic liver disease in the rat. J Hepatol 24: 368-374, 1996.
30. Ortega A, Carretero J, Obrador E, Estrela JM. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. Nitric Oxide 19: 107-114, 2008.
31. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
32. Park GY, Christman JW. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets 7: 661-668, 2006.
33. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998.
34. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, Mauri D, Burns K, Riederer BM, Akira S, Calandra T. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 106: 2348-2352, 2009.
35. Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 26: 321-329, 2004.
36. Schlag G, Redl H. Mediators of injury and inflammation. World J Surg 20: 406-410, 1996.
37. Shimada H, Nakagawara G, Kobayashi M, Tsuchiya S, Kudo T, Morita S. Pathogenesis and clinical features of acute cholangitis accompanied by shock. Jpn J Surg 14: 269-277, 1984.
38. Song XM, Li JG, Wang YL, Hu ZF, Zhou Q, Du ZH, Jia BH. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 30: 468-472, 2008.
39. Tan S, McAdams M, Royall J, Freeman BA, Parks DA. Endothelial injury from a circulating mediator following rat liver ischemia. Free Radic Biol Med 24: 427-434, 1998.
40. Terada Y, Eguchi Y, Nosaka S, Toba T, Nakamura T, Shimizu Y. Capillary endothelial thrombomodulin expression and fibrin deposition in rats with continuous and bolus lipopolysaccharide administration. Lab Invest 83: 1165-1173, 2003.
41. Tu B, Gong JP, Feng HY, Wu CX, Shi YJ, Li XH, Peng Y, Liu CA, Li SW. Role of NF-κB in multiple organ dysfunction during acute obstructive cholangitis. World J Gastroenterol 9: 179-183, 2003.
42. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs 57: 81-91, 1999.
43. Yamada S, Ogata I, Hirata K, Mochida S, Tomiya T, Fujiwara K. Intravascular coagulation in the development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats. Scand J Gastroenterol 24: 293-298, 1989.
44. Yee SB, Hanumegowda UM, Copple BL, Shibuya M, Ganey PE, Roth RA. Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure. Toxicol Sci 74: 203-214, 2003.
45. Yokoyama Y, Baveja R, Kresge N, Sonin N, Nakanishi K, Zhang JX, Gitzelmann CA, Clemens MG. Endothelin receptor remodeling induces the portal venous hyper-response to endothelin-1 following endotoxin pretreatment. Shock 17: 36-40, 2002.
46. Yokoyama Y, Baveja R, Sonin N, Nakanishi K, Zhang JX, Clemens MG. Altered endothelin receptor subtype expression in hepatic injury after ischemia/reperfusion. Shock 13: 72-78, 2000.
47. Yokoyama Y, Toth B, Kitchens WC, Schwacha MG, Bland KI, Chaudry IH. Role of thromboxane in producing portal hypertension following trauma-hemorrhage. Am J Physiol Gastrointest Liver Physiol 285: G1293-G1299, 2003.
48. Yokoyama Y, Xu H, Kresge N, Keller S, Sarmadi AH, Baveja R, Clemens MG, Zhang JX. Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol 284: G453-G460, 2003.
49. Zingarelli B, Cook JA. Peroxisome proliferator-activated receptorgamma is a new therapeutic target in sepsis and inflammation. Shock 23: 393-399, 2005.